MBAM
CSBR icon

Mink Brook Asset Management’s Champions Oncology CSBR Stock Holding History

Mink Brook Asset Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$640K Buy
111,338
+31,033
+39% +$197K 0.36% 39
2025
Q4 		$555K Buy
+80,305
New +$535K 0.35% 30

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Mink Brook Asset Management's CSBR Position: Q1 2026 in Review

Mink Brook Asset Management increased its Champions Oncology (CSBR) stake by 39% in Q1 2026, buying an estimated $197K and bringing the position to 111,338 shares worth $640K. The position accounts for 0.36% of the portfolio, ranked #39.

Mink Brook Asset Management first reported a position in CSBR in Q4 2025 and has held it in 2 quarters since. 25 funds tracked by Wall St. Rank hold CSBR as of Q1 2026.

  • Mink Brook Asset Management held 111,338 shares of Champions Oncology worth $640K as of Q1 2026.
  • Mink Brook Asset Management bought 31,033 Champions Oncology shares in Q1 2026, an estimated $197K.
  • Champions Oncology made up 0.36% of Mink Brook Asset Management's portfolio in Q1 2026, its #39 holding.
  • Mink Brook Asset Management first reported a position in Champions Oncology in Q4 2025 and has held it in 2 quarters since.
  • 25 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2026.

Based on Mink Brook Asset Management's 13F filing for Q1 2026, filed 1 Apr 2026.